Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Hitoshi YAGISAWA"'
Autor:
Nobuharu Tamaki, Masayuki Kurosaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Kouji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Toshifumi Tada, Shinichiro Nakamura, Satoshi Yasuda, Hidenori Toyoda, Rohit Loomba, Namiki Izumi
Publikováno v:
Hepatology Communications, Vol 6, Iss 3, Pp 461-472 (2022)
The identification of patients with advanced fibrosis who do not need any further hepatocellular carcinoma (HCC) surveillance after the eradication of hepatitis C is pivotal. In this study, we developed a simple serum‐based risk model that could id
Externí odkaz:
https://doaj.org/article/b270c985294642f8ba44b40f73ac4f16
Autor:
Toshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Koji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Shinichiro Nakamura, Namiki Izumi
Publikováno v:
JGH Open, Vol 6, Iss 1, Pp 20-28 (2022)
Abstract Background and Aim The pathogenic process underlying the development of hepatocellular carcinoma (HCC) is not yet clear in patients with hepatitis C virus (HCV) who have received direct‐acting antiviral (DAA) therapy and achieved sustained
Externí odkaz:
https://doaj.org/article/32a143b3a92949e48869ab1e29bd215b
Autor:
Jun Itakura, Masayuki Kurosaki, Chitomi Hasebe, Yukio Osaki, Kouji Joko, Hitoshi Yagisawa, Shinya Sakita, Hiroaki Okushin, Takashi Satou, Hiroyuki Hisai, Takehiko Abe, Keiji Tsuji, Takashi Tamada, Haruhiko Kobashi, Akeri Mitsuda, Yasushi Ide, Chikara Ogawa, Syotaro Tsuruta, Kouichi Takaguchi, Miyako Murakawa, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0165339 (2016)
We aimed to clarify the characteristics of resistance-associated substitutions (RASs) after treatment failure with NS5A inhibitor, daclatasvir (DCV) in combination with NS3/4A inhibitor, asunaprevir (ASV), in patients with chronic hepatitis C virus g
Externí odkaz:
https://doaj.org/article/b9240e38227148be9226cb4333c32437
Autor:
Masafumi Komatsu, Tsuyoshi Ono, Ko Nakajima, Itaru Toyoshima, Mitsuro Chiba, Osamu Masamune, Shunji Ohkubo, Tsukasa Yoshida, Hitoshi Yagisawa, Kanji Komatsu, Hideki Wakamatsu, Nobuo Yamada, Hiroyuki Watanabe, Tsuyoshi Mukojima, Mitsuo Goto
Publikováno v:
Canadian Journal of Gastroenterology, Vol 11, Iss 7, Pp 579-582 (1997)
Sixty-one chronic hepatitis C patients were randomly assigned to receive either 6x106 or 9x106 U of recombinant interferon-alpha-2a (IFNα-2a) six days a week for the first two weeks of treatment, followed in both cases by 6x106 U three days a week f
Externí odkaz:
https://doaj.org/article/df8e7ad5bcd94301af26af18cd67bada
Autor:
Takehiro G Kusakabe, Tsubasa Sakai, Masato Aoyama, Yuka Kitajima, Yuki Miyamoto, Toru Takigawa, Yutaka Daido, Kentaro Fujiwara, Yasuko Terashima, Yoko Sugiuchi, Giorgio Matassi, Hitoshi Yagisawa, Min Kyun Park, Honoo Satake, Motoyuki Tsuda
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e41955 (2012)
Gonadotropin-releasing hormone (GnRH) is a neuroendocrine peptide that plays a central role in the vertebrate hypothalamo-pituitary axis. The roles of GnRH in the control of vertebrate reproductive functions have been established, while its non-repro
Externí odkaz:
https://doaj.org/article/7de6af4783e64b44b8675d4f2fbc723d
Autor:
Toshifumi Tada, Masayuki Kurosaki, Nobuharu Tamaki, Yutaka Yasui, Nami Mori, Keiji Tsuji, Chitomi Hasebe, Koji Joko, Takehiro Akahane, Koichiro Furuta, Haruhiko Kobashi, Hiroyuki Kimura, Hitoshi Yagisawa, Hiroyuki Marusawa, Masahiko Kondo, Yuji Kojima, Hideo Yoshida, Yasushi Uchida, Shinichiro Nakamura, Namiki Izumi
Publikováno v:
JGH Open: An Open Access Journal of Gastroenterology and Hepatology
JGH Open, Vol 6, Iss 1, Pp 20-28 (2022)
JGH Open, Vol 6, Iss 1, Pp 20-28 (2022)
Background and Aim The pathogenic process underlying the development of hepatocellular carcinoma (HCC) is not yet clear in patients with hepatitis C virus (HCV) who have received direct‐acting antiviral (DAA) therapy and achieved sustained virologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f169600d729a8a935e7843fd409174c
http://europepmc.org/articles/PMC8762616
http://europepmc.org/articles/PMC8762616
Autor:
Namiki Izumi, Yuji Kojima, Kouji Joko, Hiroyuki Kimura, Yutaka Yasui, Masayuki Kurosaki, Hidenori Toyoda, Satoshi Yasuda, Rohit Loomba, Hideo Yoshida, Hiroyuki Marusawa, Chitomi Hasebe, Keiji Tsuji, Haruhiko Kobashi, Hitoshi Yagisawa, Masahiko Kondo, Takehiro Akahane, Shinichiro Nakamura, Yasushi Uchida, Nami Mori, Koichiro Furuta, Nobuharu Tamaki, Toshifumi Tada
Publikováno v:
Hepatology communications, vol 6, iss 3
The identification of patients with advanced fibrosis who do not need any further hepatocellular carcinoma (HCC) surveillance after the eradication of hepatitis C is pivotal. In this study, we developed a simple serum-based risk model that could iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20283c89ae1166d7936a4cc8d1b2fedf
https://doi.org/10.1002/hep4.1833
https://doi.org/10.1002/hep4.1833
Autor:
Takashi Sato, Hiroyuki Kimura, Chikara Ogawa, Hirotaka Arai, Nami Mori, Masayuki Kurosaki, Atsunori Kusakabe, Takehiro Akahane, Kouji Joko, Masahiko Kondo, Chitomi Hasebe, Yasushi Ide, Shinichiro Nakamura, Koichiro Furuta, Toshifumi Tada, Akeri Mitsuda, Namiki Izumi, Hitoshi Yagisawa, Yasushi Uchida, Hiroyuki Marusawa, Haruhiko Kobashi, Yuji Kojima, Ryoichi Narita, Keiji Tsuji
Publikováno v:
Journal of Medical Virology. 93:6247-6256
The real-world virological efficacy and safety of interferon-free direct-acting antiviral (DAA) therapy with sofosbuvir (SOF) and velpatasvir (VEL) were assessed in hepatitis C virus (HCV) genotype 1- and 2-infected patients with decompensated cirrho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2a82460d15c40a60aa82a873555a688
https://doi.org/10.1002/jmv.27157
https://doi.org/10.1002/jmv.27157
Autor:
Koji Joko, Rohit Loomba, Koichiro Furuta, Yutaka Yasui, Masayuki Kurosaki, Yuji Kojima, Hiroyuki Kimura, Masahiko Kondo, Chitomi Hasebe, Nami Mori, Haruhiko Kobashi, Namiki Izumi, Nobuharu Tamaki, Hideo Yoshida, Takehiro Akahane, Keiji Tsuji, Hitoshi Yagisawa, Hiroyuki Marusawa, Yasushi Uchida
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol 73, iss 9
Clin Infect Dis
Clin Infect Dis
Background It is unclear whether the fibrosis 4 index (FIB-4), a marker of liver fibrosis, at baseline and change in FIB-4 after sustained virological response (SVR) is associated with incident hepatocellular carcinoma (HCC) risk. In this study, we e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1c23dc5d09fa2f8df668e5ffc4d4316
https://escholarship.org/uc/item/5hv334rh
https://escholarship.org/uc/item/5hv334rh
Autor:
Takehiko Abe, Yuji Kojima, Masayuki Kurosaki, Keiji Tsuji, Haruhiko Kobashi, Takehiro Akahane, Sakura Kirino, Tomomichi Matsushita, Hideo Yoshida, Chitomi Hasebe, Hiroyuki Marusawa, Hiroyuki Kimura, Yasushi Uchida, Atsunori Kusakabe, Masahiko Kondo, Namiki Izumi, Hitoshi Yagisawa, Nobuharu Tamaki, Kouji Joko, Shun Kaneko
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Nucleos(t)ide analogs (NA) suppress hepatitis B virus (HBV) replication and reduce the risk of hepatocellular carcinoma (HCC). However, NA cannot suppress carcinogenesis completely in patients with chronic hepatitis B. The aims of this study were to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2359a17dbc7cac8859424f32913c9159
https://doi.org/10.1038/s41598-020-69522-w
https://doi.org/10.1038/s41598-020-69522-w